Semaglutide, however, has the most mature evidence for cardiovascular risk reduction, as demonstrated in the SUSTAIN-6, PIONEER-6, and SELECT trials
It changes what happens downstream in the clinical compounding ecosystem
However, while some benefits have been observed, the evidence is not definitive and further research is required in these areas
By combining genetic context with your provider's clinical assessment, you gain a foundation for discussing whether standard dosing, extended intervals, or compounded microdose protocols align best with your metabolic and genetic profilemoving beyond generic one-size-fits-all approaches
Sunrise says it works with insurance providers to help patients pay $25 a month or less for GLP-1 medications after meeting their deductible
We also ensure our products are NSF for Sport certified, meaning they have been rigorously tested for purity and are safe for everyone from professional athletes to those just starting their wellness journey